Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin
Metadherin (MTDH), also known as astrocyte-elevated gene-1, was first cloned in 2002 and has been confirmed as an oncogene in numerous types of cancer by previous studies. Overexpression of MTDH has been observed in multiple types of cancer, including breast, esophageal, prostate, cervical and non-s...
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
D.A. Spandidos
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438956/ |